Lindbrook Capital’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $27.4K | Buy |
309
+9
| +3% | +$797 | ﹤0.01% | 1220 |
|
|
2024
Q4 | $26.2K | Buy |
300
+1
| +0.3% | +$87 | ﹤0.01% | 1130 |
|
|
2024
Q3 | $27.7K | Sell |
299
-14
| -4% | -$1.3K | ﹤0.01% | 1114 |
|
|
2024
Q2 | $33.7K | Sell |
313
-38
| -11% | -$4.1K | ﹤0.01% | 969 |
|
|
2024
Q1 | $33.3K | Buy |
351
+9
| +3% | +$854 | ﹤0.01% | 958 |
|
|
2023
Q4 | $31.5K | Sell |
342
-38
| -10% | -$3.51K | ﹤0.01% | 959 |
|
|
2023
Q3 | $19.1K | Buy |
380
+7
| +2% | +$352 | ﹤0.01% | 1080 |
|
|
2023
Q2 | $23.6K | Buy |
373
+59
| +19% | +$3.73K | ﹤0.01% | 1002 |
|
|
2023
Q1 | $14.1K | Buy |
314
+189
| +151% | +$8.5K | ﹤0.01% | 1240 |
|
|
2022
Q4 | $5.48K | Sell |
125
-170
| -58% | -$7.45K | ﹤0.01% | 1775 |
|
|
2022
Q3 | $19K | Hold |
295
| – | – | ﹤0.01% | 997 |
|
|
2022
Q2 | $15K | Sell |
295
-13
| -4% | -$661 | ﹤0.01% | 1084 |
|
|
2022
Q1 | $20K | Sell |
308
-649
| -68% | -$42.1K | ﹤0.01% | 994 |
|
|
2021
Q4 | $103K | Buy |
957
+956
| +95,600% | +$103K | 0.02% | 483 |
|
|
2021
Q3 | $0 | Sell |
1
-23
| -96% | – | ﹤0.01% | 1866 |
|
|
2021
Q2 | $2K | Buy |
24
+1
| +4% | +$83 | ﹤0.01% | 1559 |
|
|
2021
Q1 | $2K | Buy |
23
+8
| +53% | +$696 | ﹤0.01% | 1517 |
|
|
2020
Q4 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 1424 |
|